AFT — AFT Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	106	113	130	157	195
Cost of Revenue
Gross Profit	48.3	48.7	61.8	73	88.3
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	84.4	102	110	137	171
Operating Profit	21.2	10.7	20.4	19.7	24.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12.9	7.89	18.7	15.8	22
Provision for Income Taxes
Net Income After Taxes	12.7	7.78	19.8	10.7	15.6
Net Income Before Extraordinary Items
Net Income	12.7	7.78	19.8	10.7	15.6
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11.7	7.59	19.8	10.7	15.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.021	0.074	0.19	0.102	0.149
Dividends per Share